Starting Sunday, Nov. 28, our RSNA 2004 Webcast will feature reports and images from Chicago, as our team sends continuing coverage of scientific sessions, exhibits and product launches, and special addresses and presentations, targeting the latest advances and controversies in the field.
Starting Sunday, Nov. 28, our RSNA 2004 Webcast will feature reports and images from Chicago, as our team sends continuing coverage of scientific sessions, exhibits and product launches, and special addresses and presentations, targeting the latest advances and controversies in the field.
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.
Can MRI-Based AI Bolster Biopsy Decision-Making in PI-RADS 3 Cases?
December 9th 2024In patients with PI-RADS 3 lesion assessments, the combination of AI and prostate-specific antigen density (PSAD) level achieved a 78 percent sensitivity and 93 percent negative predictive value for clinically significant prostate cancer (csPCa), according to research presented at the Radiological Society of North American (RSNA) conference.